Business
Hardman report: New Affimer opportunities
Hardman report: New Affimer opportunities.
About this update from Avacta Group Plc
[{"type":"text","content":"\n \nRNS Number : 5242E Avacta Group PLC 19 July 2016 \n\n \nHardman report: New Affimer development opportunities\n \nHardman & Co research report: New Affimer development opportunities\nAvacta is a life science company providing high quality and highly specific tools to the biopharmaceutical industry to help in the diagnosis and treatment of humans and animals. The group's Affimer technology is a revolutionary alternative to the established antibody technology which dominates the drug industry despite its limitations. While Avacta has made considerable progress towards developing its own bio-therapeutics in 2016, two announcements recently have expanded its Affimer technology into new areas with large commercial potential. There remains a clear mismatch between the current EV and the long-term potential of Affimers.\n \nPlease click here for the full report:\n \nhttp://hardmanandco.com/docs/default-source/company-docs/avacta-documents/18-07-16-new-affimer-development-opportunities\n \n \n\n\n\n\nTo contact us: \nHardman & Co\n11/12 Tokenhouse Yard \nLondon\nEC2R 7AS\n\n\nContact: Dr Martin Hall [email protected] \nDr Gregoire Pave\[email protected] \nTelephone: +44 20 7929 3399\nFollow us on Twitter @HardmanandCo\n \n\n\n\n\n \nwww.hardmanandco.com \n \nAbout Hardman & Co: For the past 20 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.\n \nHardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.\n \nOur research is provid...